NICE has today announced a major boost for contact centres across the global COVID-19 vaccine supply chain using its cloud platform named CXone. NICE, which works with organisations of all sizes to create extraordinary and trustworthy customer experiences that create deeper brand loyalty and relationships that last, will offer up the CXone, dubbed the industry’s most complete cloud customer experience platform with the aim to combine top of the range customer analytics, omnichannel routing, workforce optimisation, automation and artificial intelligence all on an open cloud foundation to help organisations truly transform every single customer interaction.
The supply chain for the crucial COVID-19 vaccine – created and trialled by Pfizer and Astra-Zeneca – is made up of three crunch stakeholders. These are healthcare providers, vaccine manufacturers and national agencies that are responsible for the distribution of the jabs.
Platform Eliminates Administration Bottlenecks
NICE CXone guarantees flawless and clear communication throughout at a time of high anxiety when governments are scrambling to build and scale this historic administration strategy, with a feature that also eliminating bottlenecks.
Paul Jarman, NICE inContact CEO said: “This is a historic moment, and contact centers play a critical role in efficiently distributing and building trust in the COVID-19 vaccine.
“As the vaccine rollout unfolds, information and service centers across the pharmaceutical industry, health departments, government agencies, distribution companies and pharmacies need to quickly ramp up customer service as needed.”
He added: “CXone equips all of them with innovative cloud technology that drives flexibility, reliability and agility in the face of such a grand-scale effort.”